ClinConnect ClinConnect Logo
Search / Trial NCT06041997

Smartphone Use Restriction as Treatment of Primary Headache

Launched by ALL INDIA INSTITUTE OF MEDICAL SCIENCES · Sep 12, 2023

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is exploring whether limiting smartphone use can help people who suffer from primary headaches, which are headaches not caused by another condition. The researchers want to find out if cutting back on smartphone time can lead to fewer headaches, reduce the need for medication, and improve how well medications work for these patients. They will also look at whether different types of smartphone activities, like browsing the internet or making calls, affect headache severity.

To participate, individuals must be at least 18 years old and have a diagnosis of primary headache. Those interested will first answer questions about their smartphone use and then go through a 4-week period to assess their headaches before being randomly assigned to either limit their smartphone use or continue with their usual habits. The trial is currently recruiting participants, and it aims to identify if smartphone use restrictions can be a helpful, non-drug treatment option for managing headaches.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Patients ≥18 years of age
  • 2. Diagnosis of primary headache as per the ICHD3Beta classification ("ICHD-3 The International Classification of Headache Disorders 3rd Edition" n.d.)
  • 3. Willing and consenting to participate in the study.
  • Exclusion Criteria:
  • 1. Secondary headaches 2. Not consenting for participation or follow up

About All India Institute Of Medical Sciences

The All India Institute of Medical Sciences (AIIMS) is a premier medical institution and research center in India, recognized for its commitment to advancing healthcare through innovative research and clinical trials. Established with the mission to provide high-quality medical education, patient care, and groundbreaking research, AIIMS plays a pivotal role in the development and evaluation of new therapies and interventions. Its multidisciplinary approach, combined with a robust infrastructure and a team of leading healthcare professionals, positions AIIMS as a key player in the global clinical research landscape, dedicated to improving health outcomes and fostering scientific excellence.

Locations

New Delhi, Delhi, India

Patients applied

0 patients applied

Trial Officials

Deepti Vibha

Principal Investigator

All India Institute of Medical Sciences

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported